Medicine
Pliaglis 70 mg/70 mg per g cream
Pliaglis 70 mg/70 mg per g cream is a prescription medicine containing Lidocaine and Tetracaine for topical use, marketed by IPG Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Refrigerate at 2 to 8°C (36 to 46°F). Do not freeze. PLIAGLIS can be stored at…
Key facts
- Active ingredient (INN)
- Lidocaine and Tetracaine
- Brand
- Pliaglis
- Strength
- 70 mg/70 mg per g
- Dosage form
- Cream
- Route
- Topical
- Packs
- 1 tube
- Marketing authorisation holder
- IPG Pharmaceuticals
- Manufacturer
- IPG Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Refrigerate at 2 to 8°C (36 to 46°F). Do not freeze. PLIAGLIS can be stored at room temperature for up to 3 months. Discard PLIAGLIS after storing at room temperature for 3 months.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 6 March 2026
- Identifiers
- RxCUI 687443, 728126DailyMed set ID d854faa5-0af8-4684-b5cd-a0b8a91fb7cdNDC 71085-100Application NDA021717
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 tube in 1 carton / 30 g in 1 tube | 71085-100-30 | Ipg Pharmaceuticals | 6 March 2026 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 June 2005 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Lidocaine and Tetracaine is a fixed-dose combination of an amide local anesthetic, an antiarrhythmic and an ester local anesthetic. It is available as cream for topical use. MedsAcross supplies Lidocaine and Tetracaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Lidocaine and TetracaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- PLIAGLIS prescribing information (Ipg Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Pliaglis 70 mg/70 mg per g cream for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.